Detalles de la búsqueda
1.
Phase III randomized study of taselisib or placebo with fulvestrant in estrogen receptor-positive, PIK3CA-mutant, HER2-negative, advanced breast cancer: the SANDPIPER trial.
Ann Oncol
; 32(2): 197-207, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33186740
2.
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations.
Ann Oncol
; 31(2): 171-190, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31959335
3.
Anthracycline-induced cardiotoxicity in patients with early-stage breast cancer: the Canadian Cancer Trials Group (CCTG) MA.21 experience.
Breast Cancer Res Treat
; 184(3): 733-741, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32940847
4.
A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213.
Breast Cancer Res Treat
; 167(2): 485-493, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29027598
5.
Trastuzumab-induced cardiotoxicity: testing a clinical risk score in a real-world cardio-oncology population.
Curr Oncol
; 24(3): 176-180, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28680277
6.
The Framingham risk score underestimates the risk of cardiovascular events in the HER2-positive breast cancer population.
Curr Oncol
; 24(5): e348-e353, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29089804
7.
A randomized, double-blind, phase II, exploratory trial evaluating the palliative benefit of either continuing pamidronate or switching to zoledronic acid in patients with high-risk bone metastases from breast cancer.
Breast Cancer Res Treat
; 155(1): 77-84, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26643085
8.
Can the referring surgeon enhance accrual of breast cancer patients to medical and radiation oncology trials? The ENHANCE study.
Curr Oncol
; 23(3): e276-9, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27330365
9.
Systemic targeted therapy for her2-positive early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline.
Curr Oncol
; 22(Suppl 1): S114-22, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25848335
10.
Optimal systemic therapy for early breast cancer in women: a clinical practice guideline.
Curr Oncol
; 22(Suppl 1): S67-81, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25848340
11.
Adjuvant chemotherapy for early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline.
Curr Oncol
; 22(Suppl 1): S82-94, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25848343
12.
Adjuvant endocrine therapy for early breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline.
Curr Oncol
; 22(Suppl 1): S95-S113, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25848344
13.
Novel agents and associated toxicities of inhibitors of the pi3k/Akt/mtor pathway for the treatment of breast cancer.
Curr Oncol
; 22(1): 33-48, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25684987
14.
Treatment outcomes for male breast cancer: a single-centre retrospective case-control study.
Curr Oncol
; 21(3): e400-7, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24940099
15.
Preference weights for chemotherapy side effects from the perspective of women with breast cancer.
Breast Cancer Res Treat
; 142(1): 101-7, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24129976
16.
NCIC CTG IND.181: phase I study of AT9283 given as a weekly 24 hour infusion in advanced malignancies.
Invest New Drugs
; 31(6): 1522-9, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24072436
17.
Clinical outcomes of women with metastatic breast cancer treated with nab-paclitaxel: experience from a single academic cancer centre.
Curr Oncol
; 20(1): 24-9, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23443761
18.
Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial.
ESMO Open
; 8(1): 100772, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36681013
19.
Prospective validation of risk prediction indexes for acute and delayed chemotherapy-induced nausea and vomiting.
Curr Oncol
; 19(6): e414-21, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23300365
20.
Acquisition of metastatic tissue from patients with bone metastases from breast cancer.
Breast Cancer Res Treat
; 129(3): 761-5, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21113656